federal_register: 2011-9765
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2011-9765 | Implantation or Injectable Dosage Form New Animal Drugs; Enrofloxacin | Rule | The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Bayer HealthCare LLC. The supplemental NADA provides for the addition of a pathogen to the indications for use of enrofloxacin solution in cattle, as a single injection, for the treatment of respiratory disease. | 2011-04-22 | 2011 | 4 | https://www.federalregister.gov/documents/2011/04/22/2011-9765/implantation-or-injectable-dosage-form-new-animal-drugs-enrofloxacin | https://www.govinfo.gov/content/pkg/FR-2011-04-22/pdf/2011-9765.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Bayer HealthCare LLC. The supplemental NADA provides for the addition of a pathogen to the... |